| VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
|---|---|---|---|---|---|---|---|---|
| TVIS42000535 | EBV | ENSG00000196557.14 | protein_coding | CACNA1H | No | No | 8912 | A0A1W2PQW2 O95180 |
| TVIS30079906 | HIV | ENSG00000196557.14 | protein_coding | CACNA1H | No | No | 8912 | A0A1W2PQW2 O95180 |
| TVIS30083071 | HIV | ENSG00000196557.14 | protein_coding | CACNA1H | No | No | 8912 | A0A1W2PQW2 O95180 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
| Gene | CACNA1H |
|---|---|
| DrugBank ID | DB01054 |
| Drug Name | Nitrendipine |
| Target ID | BE0000864 |
| UniProt ID | O95180 |
| Regulation Type | inhibitor |
| PubMed IDs | 18974361; 1846597 |
| Citations | Perez-Reyes E, Van Deusen AL, Vitko I: Molecular pharmacology of human Cav3.2 T-type Ca2+ channels: block by antihypertensives, antiarrhythmics, and their analogs. J Pharmacol Exp Ther. 2009 Feb;328(2):621-7. doi: 10.1124/jpet.108.145672. Epub 2008 Oct 30.@@Regulla S, Schneider T, Nastainczyk W, Meyer HE, Hofmann F: Identification of the site of interaction of the dihydropyridine channel blockers nitrendipine and azidopine with the calcium-channel alpha 1 subunit. EMBO J. 1991 Jan;10(1):45-9. |
| Groups | Approved; Investigational |
| Direct Classification | Dihydropyridinecarboxylic acids and derivatives |
| SMILES | CCOC(=O)C1=C(C)NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OC |
| Pathways | Nitrendipine Action Pathway |
| PharmGKB | PA146096020 |
| ChEMBL | CHEMBL475534 |
